Treatment of hypertension in renal failure patients: When do we overtreat? when do we undertreat?

Blood Purification

Volumn 14, Issue 4, 1996, Pages 315-320

  Rosansky, Steven J ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Dialysis; Hypertension; Renal failure; Survival

Indexed keywords

ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOMYOPATHY; DIABETES MELLITUS; DIALYSIS; DIASTOLIC BLOOD PRESSURE; GLOMERULUS FILTRATION RATE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; PRIORITY JOURNAL; SUDDEN DEATH; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TREATMENT FAILURE;

EID: 0029739643     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000170279     Document Type: Article

References (19)

1. Joint National Committee on Detection. Evaluation, and Treatment of High Blood Pressure: 5th Report of the Joint National Committee on Detection. Evaluation, and Treatment of High Blood Pressure. Bcthesda. National Institutes of Health. 1993.
2. Fletcher AE, Bulpitt CJ: How far should blood pressure be lowered? N Engl J Med 1992;326:251-254.
3. Stamler J, Stamler R, Ncaton JD: Blood pressure, systolic and diastolic. and cardiovascular risks. US population data. Arch Intern Med 1993; 153:598-615.
4. Levy D., Garrison RJ., Savage DD., Kanncl WB, Castelli WP: Prognostic implications of echocardiogra-phically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322: 1561-1566.
5. Dahlof B, Pcnncrt K, Hansson L: Reversal of left ventricular hypertrophy in hypertensive patients: A meta-analysis of 109 treatment studies. Am J Hypertens 1992;5:95-110.
6. Silbcrberg JS. Barre PE. Prichard SS. Sniderman AD: Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989;36:286-290.
7. Huting J. Kramer W, Sehutterle G, Wizemann V: Analysis of left-ventricular changes associated with chronic hemodialysis: A noninva-sivc follow-up study. Nephron 1988; 49:284-290.
8. Mall G. Huthcr W, Schneider J, Lundin P., Ritz E: Diffuse intermyo-cardiocytie fibrosis in uremic patients. Nephrol Dial Transplant 1990;5:39-44.
9. Cannella G. Paoletti E, Dclfino R. Peloso G, Molinari S, Traverso GB: Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long-term anti-hypertensive therapy. Kidney Int 1993:44:881-886.
10. Cheigh JS. Milite C. Sullivan JF. Rubin AL. Stenzel KH: Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis 1992;19:453-459.
11. Cheigh JS., Serur D., Paguirigan M., Stenzel KH, Rubin A: How' well is hypertension controlled in CAPD patients? Adv Périt Dial 1994:10: 55-58.
12. Rosansky SJ., Johnson KI., Hutchinson C, Erdel S: Blood pressure changes during daytime sleep and comparison of daytime and nighttime sleep-related blood pressure changes in patients with chronic renal failure. J Am Soc Nephrol 1993; 4:1172-1177.
13. Rostand SG. Kirk KA. Rutskv EA: Relationship of coronary' risk factors to hemodialysis-associated ischemic heart disease. Kidney Int 1982:22: 304-308.
14. Tomita J, Kimura G. Inoue T, lncn-aga T., Sanai T, Kawano Y., Nakamura S, Baba S., Matsuoka H., Omac T: Role of systolic blood pressure in determining prognosis of hemodia-lyzcd patients. Am J Kidney Dis 1995;25:205-212.
15. Charra B, Calemard E, Ruffel M, Chazot C. Terrât JC. Vanel T, Laurent G: Survival as an index of adequacy of dialysis. Kidney Int 1992; 41:1286-1291.
16. Kooman JP. Gladziwa U, Bocker G., Wijnen JA, Bortel L., Luik AJ., de Leeuw PW, van Hoff JP., Leunisscn KM: Blood pressure during the in-terdialytic period in hemodialysis patients: Estimation of representative blood pressure values. Nephrol Dial Transplant 1992;7:917-923.
17. Farnett L. Mulrow CD, Linn WD. Lucey CR, Tulcy MR: The J-curve phenomenon and the treatment of hypertension: Is there a point beyond which pressure reduction is dangerous? JAMA 1991:265:498-495.
18. Alderman MH, Ooi WL. Madhavan S, Cohen H: Treatment-induced blood pressure reduction and the risk of myocardial infarction. JAMA 1989;262:920-924.
19. Ritz E, Strumpf C., Katz F., Wing AJ., Quellhorst E: Hypertension and cardiovascular risk factors in hemodia-lyzcd diabetic patients. Hypertension 1985;7:118-124.